Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. liver transplantation
Show results for
Products
Services
Applications

Companies

News
Articles
Magazines

Refine by
Date

  • Older

Liver Transplantation Articles & Analysis

15 news found

Biopharma Stock News Bite - Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) Spikes on News Potential Treatment for Alcohol Use Disorder

Biopharma Stock News Bite - Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) Spikes on News Potential Treatment for Alcohol Use Disorder

The published study provides a comprehensive analysis of the liver safety profile of AD04 compared to a placebo in individuals with AUD and a specific 5-marker genetic profile. AUD, characterized by compulsive alcohol consumption and loss of control over intake, poses significant health risks and is a major contributor to alcohol-associated liver disease (ALD), a ...

ByInvestorideas.com


LISCure`s Phase 2 Drug Candidate Granted Orphan Drug Designation (ODD) from US FDA

LISCure`s Phase 2 Drug Candidate Granted Orphan Drug Designation (ODD) from US FDA

In addition, the likelihood of successfully developing the orphan drug is increased with the Agency's support when designing the drug development strategy. PSC is a chronic cholestatic liver disease that is caused by bile duct inflammation and fibrosis of unknown cause. The inflammation can stop the flow of bile acids and lead to liver fibrosis or ...

ByLISCure Biosciences Inc.


Alnylam and Regeneron Report Promising Data from Ongoing Phase 1 Study of ALN-HSD in NASH Patients and Healthy Volunteers

Alnylam and Regeneron Report Promising Data from Ongoing Phase 1 Study of ALN-HSD in NASH Patients and Healthy Volunteers

In the first two Part B cohorts, ALN-HSD was associated with robust target knockdown and numerically lower liver enzymes and biopsy-derived nonalcoholic fatty liver disease (NAFLD) Activity Score (NAS)* over six months in patients receiving ALN-HSD (N=20) relative to placebo (N=4). ...

ByAlnylam Pharmaceuticals, Inc.


ASC Therapeutics, UMass Chan Medical School, and the Clinic for Special Children Announce Podium Presentation of Safety and Efficacy in Murine and Bovine Models for Novel Gene Therapy in Maple Syrup Urine Disease

ASC Therapeutics, UMass Chan Medical School, and the Clinic for Special Children Announce Podium Presentation of Safety and Efficacy in Murine and Bovine Models for Novel Gene Therapy in Maple Syrup Urine Disease

First known bovine model used to demonstrate safety and efficacy in gene replacement therapy MSUD is a severe genetic disease with liver transplantation or dietary restriction as the only treatments currently available ASC Therapeutics in partnership with the UMass Chan Medical School and the Clinic for Special Children (CSC), presented safety and efficacy ...

ByASC Therapeutics


Lumos Pharma Announces a Clinical Collaboration with Massachusetts General Hospital (MGH) to Evaluate Oral LUM-201 in Nonalcoholic Fatty Liver Disease (NAFLD) in a Phase 2 Investigator-Initiated Trial

Lumos Pharma Announces a Clinical Collaboration with Massachusetts General Hospital (MGH) to Evaluate Oral LUM-201 in Nonalcoholic Fatty Liver Disease (NAFLD) in a Phase 2 Investigator-Initiated Trial

Hepatic steatosis can progress to nonalcoholic steatohepatitis (NASH) with fibrosis, and NASH-associated liver failure is one of the leading causes of liver transplant in the United States. ...

ByLumos Pharma


Biocartis Reports Results of First Quarter of 2022: On Track to Deliver on Full-Year Guidance, Gross Margin on Products of 35%

Biocartis Reports Results of First Quarter of 2022: On Track to Deliver on Full-Year Guidance, Gross Margin on Products of 35%

New partnership agreement with Ophiomics (Portugal), initially focused on the commercialization of HepatoPredictā„¢, a prognostic gene expression signature test to help identify which patients could benefit from curative-intent surgery, in particular liver transplantation. Continued ramp-up of the fully automated ML2 manufacturing line with the transfer of ...

ByBiocartis NV


Dicerna Presents Data From Phase 1 Trial of Belcesiran at American Association for the Study of Liver Diseases (AASLD) The Liver MeetingĀ® 2021

Dicerna Presents Data From Phase 1 Trial of Belcesiran at American Association for the Study of Liver Diseases (AASLD) The Liver MeetingĀ® 2021

The data were presented in a poster at The Liver MeetingĀ® 2021, the annual meeting of the American Association for the Study of Liver Diseases (AASLD). ā€œIn people with AATLD, misfolded AAT aggregates in the liver and causes liver injury that may progress to liver fibrosis, cirrhosis and hepatocellular ...

ByNovo Nordisk A/S


A Complete Overview of a Life Saving Treatment - Liver Transplantation in India

A Complete Overview of a Life Saving Treatment - Liver Transplantation in India

Hepatic transplant or liver transplant is a treatment that includes the replacement of diseased liver with the healthy liver from another individual. ...

ByLiver Transplant India


Why do you require to have a Liver transplant?

Why do you require to have a Liver transplant?

If anyhow, your liver stops working properly, you may need a liver transplant. Liver Transplant India is generally recommended if you have a last-stage liver disease, which is chronic liver failure. ...

ByLiver Transplant India


HemoShear Therapeutics Announces First Two Patients Dosed in Phase 2 Study of Oral Small Molecule HST5040 for Methylmalonic Acidemia (MMA) and Propionic Acidemia (PA)

HemoShear Therapeutics Announces First Two Patients Dosed in Phase 2 Study of Oral Small Molecule HST5040 for Methylmalonic Acidemia (MMA) and Propionic Acidemia (PA)

Despite the current standard of care involving dietary control, carnitine supplementation and in more severe cases, organ transplantation, there remains a high unmet medical need in MMA and PA. As a small molecule, HST5040 has the ability to distribute to all affected tissues and thus has the potential to be active throughout the body, including the liver, ...

ByHemoShear Therapeutics, Inc.


64% vaccine turnout after 2 days, government expects footfall to rise

64% vaccine turnout after 2 days, government expects footfall to rise

NEW DELHI: Around 64% of 3,16,375 planned beneficiaries were vaccinated on the first two days of the immunisation drive against Covid-19 that was rolled out on Saturday, preliminary data from states, subject to further correction, compiled by the Centre till Sunday evening showed. Four states — Tamil Nadu, Punjab, Tripura and Puducherry — recorded low turnout of beneficiaries in the ...

ByLiver Transplant India


Reliable monitoring of antiviral therapy of Hepatitis C infections

Reliable monitoring of antiviral therapy of Hepatitis C infections

Hepatitis C (HCV) infection is the most common cause of liver cell carcinoma and liver transplants in Europe, which are possible late–stage effects of a chronic infection, alongside cirrhosis of the liver. ...

ByAnalytik Jena - an EndressHauser Company


PTR-MS breath test shows potential for detecting liver disease

PTR-MS breath test shows potential for detecting liver disease

Researchers at the University of Birmingham have published results that suggest a non-invasive breath test for liver disease using an IONICON PTR-MS. Elevated levels of limonene in patients have been found to be indicative of a diseased liver. ...

ByIonicon Analytik Ges.m.b.H.


Newly Discovered Cells Restore Liver Damage in Mice without Cancer Risk

The liver is unique among organs in its ability to regenerate after being damaged. ...

ByNational Institute of Environmental Health Sciences (NIEHS)


Jennerex Treats First Patients in Phase 2 JX-594 Trial for Liver Cancer

Jennerex Treats First Patients in Phase 2 JX-594 Trial for Liver Cancer

The Phase 2 trial involves treatment of patients with advanced, primary liver cancer refractory to standard therapies. Patients are randomized to receive treatment at one of two dose levels. ...

ByRex Medical, L.P.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT